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Abstract 
This investigation sought to determine the feasibility of a novel mitral ring designed to 
reshape mitral annulus on beating heart, after surgery. The mitral ring is intended to improve 
mitral leaflets coaptation to correct residual and recurrent mitral regurgitations. It could also 
provide progressive correction of mitral regurgitation. The device was tested in ex vivo 
beating heart model.  
The novel mitral ring is selectively deformable in P1, P2 and P3 segments using a dedicated 
angioplasty-type balloon. The deformation should increase leaflets' coaptation reducing 
distance between the two leaflets. It was implanted using standard surgical techniques.  The 
mock-loop is based on passive beating heart. MV functioning was evaluated in terms of 
leaflet coaptation height at P2 level using epicardial echocardiography.  
The test has been completed on 8 swine hearts.  Ring size was 30mm. The balloons were 
inserted in the connecting line. Each segment of the posterior annulus was independently 
activated over 3 progressive positions. Balloon inflation pressures were between 15 and 21 
bar. Maximum coaptation height increase was 7 mm. Mean pressure gradient across the MV 
was 1.7±0.3 mmHg post complete activation of the device. 
The device allowed significant increase in coaptation height at P2 level after adjustments at 
P1, P2 and P3. Results were consistent and reproducible. This feasibility study demonstrates 
the possibility to reshape the mitral annulus on beating heart to precisely increase MV leaflets' 
coaptation height. 
Keywords: mitral repair annuloplasty, mitral regurgitation, surgical mitral repair, heart failure, 
mitral repair ring, minimally invasive mitral repair.  
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Introduction 
The surgical repair of mitral regurgitation (MR), in some patients, could became a real 
challenge even for experienced cardiac surgeons. In some degenerative MR, the complex 
reconstruction could culminate in residual MR that is typically underestimated under general 
anaesthesia. If the residual MR is more than moderate, the surgeon tends to replace the valve 
even if the replacement harms left ventricular remodelling and has negative impact on long 
term survival (1). In case of less than moderate residual MR, the surgeon tends to accept the 
compromise of incomplete repair of the regurgitation. Both solutions are frustrating for the 
surgeon and have negative impact on patient’s long term outcome (1,2).  In some functional 
MR associated to poor left ventricular function, the complete correction of the MR with an 
undersized ring is historically associated to post operative left heart failure due to the sudden 
increase in the left ventricle afterload (3,4). Therefore, the surgeon has to choose between 
leaving the MR untreated and let the disease take its fatal course or being ready to use 
inotropic and circulatory support in the post operative phase which dramatically increases the 
mortality and morbidity risks (4). The surgeon and the patient are both uncomfortable with 
these solutions.  
Independently from the pathophysiology, regurgitation is always a lack of leaflets coaptation. 
A device able to increase the coaptation length of mitral leaflets only in the area where 
residual or recurrent MR is present would definitely improve the quality of the surgical repair 
and probably the clinical outcome, potentially reducing the need for mitral valve (MV) 
replacement. Also a device able to progressively increase mitral leaflets coaptation would 
allow the progressive increase in the afterload of the left ventricle possibly reducing post-
operative complications in patients with poor left ventricle function (3). A device that could 
performs both these functions with a trans-catheter approach would avoid reoperation. 
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In this paper we present a device for MV annuloplasty conceived for reshaping the mitral 
annulus after surgical implantation using trans-catheter technique. 
The primary endpoint of the study is to validate the hypothesis that a novel mitral ring can 
increase the coaptation height of MV leaflets on ex vivo beating heart in a mock circulatory 
loop. Secondary endpoints are to assess the technical feasibility of the procedure and the 
functional assessment of the MV. 
Methods 
Device description. The MitralMaster (MiMa), (Kephalios SA, Aix-en-Provence, FR) is an 
original ring for mitral valve annuloplasty adding to the functional features of the classic 
Carpentier-Edwards mitral ring, the possibility of reshape the mitral annulus any time after 
the surgical implant. The reshaping process could be done in several steps and over the time. 
The device consists of rigid ring sutured to the mitral annulus using interrupted suture 
technique and a connecting line that links the ring to the subcutaneous tissue where it would 
be easy to access any time after the operation. The connecting line allows a dedicate balloon 
to reach mitral annulus from skin incision using trans-catheter technique, under 
echocardiographic and/or fluoroscopic guidance. The balloon is inflated with saline solution, 
deflated after 15sec and then retrieved. The balloon catheter is not permanently implanted. 
Balloon inflation results in permanent ring deformation and the ring itself guarantees the 
durability of the deformation (figures 1 and 2). It’s the ring itself that guarantees the 
durability of the deformation. Deformation segments of the ring correspond to the anatomical 
regions of the posterior mitral annulus P1, P2 and P3. Each segment can be deformed 
independently from other segments (figure 3). Each segment has a deformation range of 1 to 5 
mm (figure 2). The balloon is retrieved at the end of the procedure. The connecting line stays 
in place. The deformation of the ring is intended to increase mitral leaflets coaptation 
reducing the distance between anterior and posterior leaflets. 
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Mock circulatory loop with passive beating heart.       
The mock loop was described in detail elsewhere (5,6). Briefly, it consisted of a pulsatile 
volumetric pump, a hydraulic afterload mimicking the input impedance of the human 
systemic circulation, and an atrial preload that closed the hydraulic loop. The mock loop was 
instrumented to allow for experimental hydrodynamic investigation on the implanted device 
in simulated rest conditions. Pressures were acquired with piezoelectric transducers (140PC 
series, Honeywell Inc, Morristown, NJ, USA) placed in the systemic impedance simulator 
(Psis, Figure 4), in left atrium and in the ventricle (Patr and Pven respectively). MV and AV flow 
rates (Qmv and Qav respectively) were acquired with time-transient flow meters equipped with 
1” proves (HT110R, Transonic Systems Inc, Ithaca, NY, USA). One probe was placed 
upstream from the MV, and the other downstream to the AV. Data were sampled at 200Hz 
and recorded with an A/D board (USB6210, National Instruments, Austin, TX, USA). 
Experimental procedure and data collection 
In adult swine’s heart the mitral valve was exposed through left atrium incision. The valve 
was assessed for integrity and the distance between the trigons measured to select valves 
having this distance between 30 and 32 mm. The ring (size 30) was then sutured using 
interrupted suture technique with 2/0 Tycron (figure 5).  Sutures’ needles are inserted into 
dedicated “button holes” on the inner surface of the ring to simplify the surgical procedure 
and avoid accidental damage of fragile components of the device.  In 3 samples, mitral 
leaflets received ink spots markers to provide a qualitative visual evaluation of coaptation 
area changes. The connecting line exit the left atrium trough the surgical incision.  The heart 
was housed into the mock loop as elsewhere detailed, and the circulation started simulating 
physiological rest conditions (60 bpm of heart rate, 65mL of stroke volume imposed by the 
pump). Saline solution at 37° C was used as working fluid. To assess proper working 
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conditions in the mock loop, the following quantities were acquired in all the tested samples 
following ring implantation:  
 CO: cardiac output evaluated from the AV flow curves (Qav). 
 Part: mean simulated arterial pressure, evaluated from Psis 
Moreover, in three heart samples the following hydrodynamic quantities were evaluated and 
compared ante and post ring activation in P1, P2 and P3: 
 Q mv, sys: mean MV systolic leakage evaluated from the MV flow curve Qmv. 
 Pmv, dia: mean diastolic pressure drop across the MV (mean value of Patr-Pven evaluated 
over the diastole). 
A 5 mm diameter fiberscope (ENF-GP, Olympus Corp, Tokyo, Japan) was then inserted in 
the left atrium to acquire images of the mitral valve and the mitral ring during the simulated 
cardiac cycle. A cardiac ultrasound (HDI5000, Philips, Eindhoven, The Netherlands) was 
used to acquire images of the mitral valve from epicardium (figure 6). Specifically, the height 
of the mitral leaflets coaptation (HMC) at P2 level was acquired in baseline conditions. Then, 
the balloon was inflated in P2 position at increasing pressures in order to achieve small, 
medium and large displacement of the P2 part of the ring. The procedure was repeated for P1 
and P3. For each sample a total of 13 echo measurements were taken. The changes in HMC 
were recorded. 
Statistical analysis 
Raw data were analysed calculating mean and standard deviation. Pre and post-activation 
hydrodynamic data were compared with Mann Whitney test. Pearson's chi-squared test (χ2) 
was applied to sets of categorical data (HMC) to evaluate how likely it is that any observed 
difference between the sets arose by chance. A p<0.05 was considered significant. 
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Results  
The working conditions imposed by the mock loop did not changed significantly following 
device activation (p=0.112). All hearts had normal MV regurgitation (Q mv,sys changed from 
0.2±0.2 L/min pre-activation to 0.15±0.1 post-activation of the device). Ring size was 
30mm, without significant under sizing The measured cardiac output was 3.0±0.6 L/min, 
with a mean simulated systemic pressure of 86±    mmHg. The working conditions imposed 
by the mock loop did not changed significantly following device activation (p=0.112). Mean 
pressure gradient across the MV ( P, mv, dia) was 1±1.1 mmHg pre-activation, and 1.7±0.3 
post complete device activation (p=0.453). The balloons were inserted without resistance 
and positioned in blind, limit switch mode. Each segment of the posterior annulus (P1, P2, 
P3) was independently activated over 3 progressive steps (small, medium, large deformation) 
without technical failure. Balloon inflation pressures were between 15 and 21 bar. After 
activation of P2 segment, HMC increase was 3.2±0.1 mm; activation of both P2 and P1 lead 
to 5.5±0.2 mm of increase. The maximum HMC increase in P2 was 7.0 mm, and was 
recorded following complete activation of the device at maximum balloon pressurization. 
Figure 7 illustrates detailed results. The on-line movie recorded from the left atrium 
qualitatively shows the effect on coaptation of device activation.  The χ2 between baseline 
values and maximal HMC increase was < 0.01. 
Discussion 
The future of MV regurgitation treatment is towards first surgical correction followed by late, 
iterative percutaneous adjustments of leaflets coaptation, if needed. Although mitral repair is 
still considered the gold standard for the surgical treatment of functional and degenerative 
MR, clinicians started to questioning the durability of the surgical repair, particularly in 
functional MR (2,3).  A recent study analysed the outcomes of surgical treatment of severe 
ischemic MR comparing repair vs replacement and outlined that the recurrence of MR, which 
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was mostly moderate in degree, remained a progressive and excess hazard for patients 
undergoing mitral-valve repair. During the 2-year follow-up period, 58.8% of patients in the 
repair group had moderate or severe regurgitation, as compared with 3.8% in the replacement 
group (7). This deficiency in the durability of correction of MR confers a predisposition to 
heart failure, atrial fibrillation, and repeat interventions and hospitalizations (7,8).  
Improve the durability of a surgical procedure that has been established almost 40 years ago 
and is still wildly accepted, is a real challenge.  Starting from the assumption that “coaptation 
is durability” (2), we focused our efforts to improve the height of the mitral leaflets coaptation 
during the surgical repair or whenever needed and without upsetting the standard surgical 
technique. The key feature of the device evaluated in this study is its capability to improve the 
coaptation height pushing the posterior leaflet towards the anterior, therefore, reducing the 
antero-posterior distance of the native mitral annulus. The MiMa should allow to control the 
amount of posterior leaflet displacement (from 1 to 5 mm) as well as to define the area of 
displacement (P1, P2, P3 according to surgical classification of posterior leaflet areas) as 
clearly seen from the camera placed in the left atrium. All the adjustments should be feasible 
any time after implant and using trans-catheter technique. In a clinical setting, the access port 
will be placed in the right subclavian region, under the skin, as a standard pacemaker. If a 
residual or recurrent regurgitation is detected, the guiding catheter is surgically exposed and 
used to introduce the dedicate balloon in the area of the posterior mitral leaflet at the 
regurgitation level.  Balloon inflation should then displace the given area of the posterior 
leaflet towards the anterior, clearing or reducing the regurgitation. This is the first device 
offering the possibility of precisely adjust mitral leaflets coaptation with trans-catheter 
approach at any time and for several times after the implant. 
The adequate functioning of the MV requires a beating left ventricle therefore we have chosen 
a platform with passive beating heart that has already been validated for trans-catheter MV 
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repair evaluation (5). It combines a reliable simulation of physiologic MV leaflets movements 
with the possibility of direct vision of the MV and the mitral ring from the left atrium. The 
possibility to modify the preload and the afterload of the left ventricle helped us to recreate 
almost physiologic conditions for a better evaluation of the device tested.  
Balloon inflation was constantly associate to MiMa deformation in the targeted area with high 
reproducible results. The deformation length was clearly correlated  to pressure inflation in 
such a way to establish a pressure / deformation curve that is used for the pre-clinical tests. 
Basically, we identified 3 degrees of displacement (small, medium, large) for each of the 3 
areas in which the posterior leaflet is divided as illustrated in figure 7. This unique feature of 
the device tested, makes the control of the coaptation surface much more precise than other 
active annuloplasty devices in terms of parts of the posterior leaflet  (P1, P3, P3) and degree 
of coaptation (small, medium, large). Existing reshaping mitral rings (enCore SQ , Micardia 
Co. Irvine CA) act to reduce the circumference of the mitral annulus, similarly to a sphincter 
and independently from the position of the regurgitation. Their action is, therefore, less 
specific and probably less efficient.  
Results showed that the increase in HMC was reproducible and progressive (see Supplement 
Video, Supplemental Digital Content 1, http://links.lww.com/ASAIO/A119). The coaptation 
in P1 and P3 segments was difficult to measure due to the echocardiographic window 
available from the epicardium.  Interestingly, in all hearts, the displacement of P1 and P3 
segments resulted in increase in HMC at P2 level endorsing the hypothesis that the entire 
posterior part of the mitral annulus is displaced towards the anterior.  The increase in HMC is 
achieved without shrinking the mitral annulus circumference as it occurs when the surgeon 
downsizes the mitral ring to achieve better leaflets coaptation (3). This unique feature of the 
MiMa explains why MV gradients were still in the physiologic range even after the complete 
activation of the device.  
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A potential detrimental effect of moving the posterior annulus towards the anterior could be 
the displacement of the leaflets coaptation plane towards the left ventricle outflow tract 
inducing Systolic Anterior Motion (SAM) effect (9). Any of the heart treated showed SAM 
effect, however we can not exclude that, in patients with small LV chamber, hypertrophy of 
the interventricular septum and acute mitro-aortic junction, SAM could appear after complete 
activation of the device.   
The possibility of progressively correct the mitral regurgitation without iterative surgical 
interventions opens new therapeutic opportunity for functional MR in patients with low Left 
Ventricle Ejection Fraction (LVEF). These patients are at high mortality and morbidity risks 
when undergo mitral repair or replacement (10) mainly due to the sudden increase in the left 
ventricle afterload after complete correction of the MR. If the afterload increases over weeks 
or months, the left ventricle should have more time to adapt to it and this possibly reduces the 
risk of heart failure. The technique for increasing HMC after the surgical implant of the MiMa 
is trans-catheter and the procedure could be repeated any time after implant and as many 
times as necessary till the complete activation of the device making it the ideal tool to treat 
functional MR in patients with poor LVEF.   
Moreover, the device addresses recurrent MR due to progressive LV dilatation possibly 
associate with HF progression.  Each device’s activation produces an anterior displacement of 
the corresponding part of the posterior leaflet, therefore reducing posterior leaflet excursion. 
This mechanism compensates the relative shortening of the chordae due to LV dilatation, 
avoiding the risks of a second intervention.  
Conclusions 
There is a clear need for less invasive procedures to treat heart diseases in high risk patients. 
This study showed it is possible to increase the height of mitral leaflets coaptation on beating 
heart, with trans-catheter approach after implanting an original mitral ring. The procedure was 
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consistent with reproducible effects. This device could represent the new therapeutic option 
for the treatment of persistent and recurrent mitral regurgitation after surgical repair. It could 
also allow to surgically treat MR in low LVEF patients possibly reducing the complication 
rate associate to standard repair. Only the ongoing clinical studies will possibly demonstrate 
that MiMa improves long term results of mitral repair, avoids reoperation and 
rehospitalisation due to MR and allows to treat MR in patients with poor ventricular function. 
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Legends 
Figure 1. Schematic representation of the MiMa working principle. The balloon is inserted in 
the connecting line (d) and advanced till the P2 segment (a and b). The balloon is then inflated 
causing permanent deformation of the ring in the P2 area (c). After the procedure, the balloon 
is retrieved.  
 
Figure 2. Schematic representation of progressive deformation of the ring. The P2 segment is 
displaced towards the anterior leaflet of 2mm (a), 3mm (b) or 5mm (c) depending on balloon 
inflation.  Maximum displacement is achieved in one or more steps over time, according to 
patient’s need. 
 
Figure 3. The 3 anatomical segments of the posterior leaflet are displaced independently from 
each other. Maximum expansion of the 3 segments corresponds to the maximum 
displacement of the posterior leaflet towards the anterior leaflet that MiMa can achieve.  
 
Figure 4. Right, a photography, and left, a schematic of the pulsatile mock loop. PD: pulse 
duplicator; LV: left ventricle; SIS: systemic impedance simulator; PR: preload reservoir; Pven: 
ventricular pressure; Patr: left atrium pressure; Psis: arterial pressure. Qmv: mitral valve flow; 
Qao: aortic valve flow. 
 
Figure 5. Integrity of the mitral valve has been assessed. Inter trigon distance is 32. The ring 
(size 30) is sutured on the mitral annulus using interrupted 2/0 Tycron sutures. The 
connecting line exit the left atrium at the level of the right end of the atrial incision (a). A 
plastic flange (b) is sutured to the aorta to facilitate the connection to the mock circuit. A 
similar flange is inserted into the left ventricle trough the apex to connecting the heart to the 
mock circuit.  
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Figure 6. Echocardiogram with epicardic view of the 4 cavities. LA: left atrium; LV: left 
ventricle; a: height of mitral leaflets coaptation (HMC); b: ring at the level of A2.  
 
Figure 7. Detailed results on average coaptation increase (HMC) associate to small, medium 
and large deformation of each P segments. The amount of deformation depends on inflation 
balloon pressure.  
 
Video. Left atrial view of the MiMa during P2 segment activation. The ring has been sutured 
using 2/0 interrupted suture technique. Balloon in P2 position is progressively inflated 
causing the anterior displacement of P2 portion of the posterior leaflet. 
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Figure 1. 
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Figure 2. 
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Figure 3. 
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Figure 4. 
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Figure 5. 
 
  
Copyright © 2016 by the American Society for Artificial Internal Organs
AC
CE
PT
ED
20 
 
Figure 6. 
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Figure 7. 
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